IL18 and familial pancreatic carcinoma: The simultaneous inhibition of the IL-18 and PD-L1/PD-1 pathways using synthetic inhibitors leads to reduced PDAC growth and metastasis in orthotopic animal models, highlighting the in vivo significance of Breg–cancer cell crosstalk in the progression of pancreatic cancer [295].